These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31740742)

  • 1. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
    Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X
    Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
    He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
    Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Expression of
    Chen C; Chen Z; Chio CL; Zhao Y; Li Y; Liu Z; Jin Z; Wu X; Wei W; Zhao Q; Li Y
    Technol Cancer Res Treat; 2021; 20():15330338211052152. PubMed ID: 34738847
    [No Abstract]   [Full Text] [Related]  

  • 5. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
    Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F
    PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics.
    He X; Hu J; Yan C; Liu X; Zhao Y; Yang P; Wang J; Li S; Zhang W; Dong G; Zhang W; Jing H
    Cancer Biomark; 2023; 36(3):221-230. PubMed ID: 36938721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD
    Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
    Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
    Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
    Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
    J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression level of Neuronal Calcium Sensor 1 can predict the prognosis of cytogenetically normal AML.
    Zhang W; Wang J; Li W; Liu X; Zhao Y; Yang P; Zhu M; Hu K; Li S; Dong G; Yan C; He X; Zhang X; Jing H
    Pharmacogenomics J; 2023 Jul; 23(4):89-94. PubMed ID: 36918700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
    Mrózek K; Marcucci G; Paschka P; Whitman SP; Bloomfield CD
    Blood; 2007 Jan; 109(2):431-48. PubMed ID: 16960150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.
    Tao Y; Wei L; Shiba N; Tomizawa D; Hayashi Y; Ogawa S; Chen L; You H
    Mol Biomed; 2024 Jan; 5(1):1. PubMed ID: 38163849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
    Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.
    Ma QL; Wang JH; Yang M; Wang HP; Jin J
    J Transl Med; 2018 Mar; 16(1):68. PubMed ID: 29540187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis.
    Shi J; Shi X; Dai RQ
    Hematology; 2020 Dec; 25(1):219-228. PubMed ID: 33346694
    [No Abstract]   [Full Text] [Related]  

  • 18. High expression of RUNX1 is associated with poorer outcomes in cytogenetically normal acute myeloid leukemia.
    Fu L; Fu H; Tian L; Xu K; Hu K; Wang J; Wang J; Jing H; Shi J; Ke X
    Oncotarget; 2016 Mar; 7(13):15828-39. PubMed ID: 26910834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts.
    Lin SY; Miao YR; Hu FF; Hu H; Zhang Q; Li Q; Chen Z; Guo AY
    J Cancer; 2020; 11(1):251-259. PubMed ID: 31892991
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
    Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP
    Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.